Willey C - Search Results

1

Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure.

Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, Melbourne K, Mitty J, Caro JJ. Willey C, et al. Clin Ther. 2000 Jul;22(7):858-71. doi: 10.1016/s0149-2918(00)80058-2. Clin Ther. 2000. PMID: 10945512

2

Behavior-changing methods for improving adherence to medication.

Willey C. Willey C. Curr Hypertens Rep. 1999 Dec;1(6):477-81. doi: 10.1007/s11906-996-0019-6. Curr Hypertens Rep. 1999. PMID: 10981109

3

Stages of change for adherence to antiretroviral medications.

Genberg BL, Lee Y, Rogers WH, Willey C, Wilson IB. Genberg BL, et al. Among authors: willey c. AIDS Patient Care STDS. 2013 Oct;27(10):567-72. doi: 10.1089/apc.2013.0126. AIDS Patient Care STDS. 2013. PMID: 24093810 Free PMC article. Clinical Trial.

4

Compliance-related problems in the ambulatory population.

Larrat EP, Taubman AH, Willey C. Larrat EP, et al. Among authors: willey c. Am Pharm. 1990 Feb;NS30(2):18-23. doi: 10.1016/s0160-3450(15)31554-3. Am Pharm. 1990. PMID: 2305669

5

How Did Research on Medication Safety in Pregnancy Define, Develop and Advance the Field of Pharmacoepidemiology?

Willey C, Calip GS. Willey C, et al. Clin Ther. 2019 Dec;41(12):2464-2466. doi: 10.1016/j.clinthera.2019.11.004. Epub 2019 Dec 3. Clin Ther. 2019. PMID: 31810581 No abstract available.

6

Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease?

Adesanoye DT, Willey CJ. Adesanoye DT, et al. Ann Pharmacother. 2017 Oct;51(10):855-861. doi: 10.1177/1060028017712531. Epub 2017 Jun 2. Ann Pharmacother. 2017. PMID: 28573879

7

Stages of change for reducing dietary fat to 30% of energy or less.

Greene GW, Rossi SR, Reed GR, Willey C, Prochaska JO. Greene GW, et al. Among authors: willey c. J Am Diet Assoc. 1994 Oct;94(10):1105-10; quiz 1111-2. doi: 10.1016/0002-8223(94)91127-4. J Am Diet Assoc. 1994. PMID: 7930314 Clinical Trial.

8

Changing trends in antihypertensive therapy in two New England communities during the 1980s.

Hume AL, Barbour MM, Willey CJ, Assaf AR, Lapane KL, Carleton RA. Hume AL, et al. Among authors: willey cj. Pharmacotherapy. 1993 May-Jun;13(3):244-51. Pharmacotherapy. 1993. PMID: 8100629

9

Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation).

Kogut SJ, Andrade SE, Willey C, Larrat EP. Kogut SJ, et al. Among authors: willey c. Pharmacoepidemiol Drug Saf. 2004 Sep;13(9):591-8. doi: 10.1002/pds.1005. Pharmacoepidemiol Drug Saf. 2004. PMID: 15362081

10

Real-World Health Care Costs Based on Medication Adherence and Risk of Stroke and Bleeding in Patients Treated with Novel Anticoagulant Therapy.

Deshpande CG, Kogut S, Willey C. Deshpande CG, et al. Among authors: willey c. J Manag Care Spec Pharm. 2018 May;24(5):430-439. doi: 10.18553/jmcp.2018.24.5.430. J Manag Care Spec Pharm. 2018. PMID: 29694285 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page